Cytokine synthesis by MEK1/2 and p38 is tightly controlled and each tier of the MAPK signalling cascade is subject to regulation which may be impaired in CFS/ME patients [46, 53]. The gene discussed is MAPK14; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.